Pharmacokinetics and comparative bioavailability of allopurinol formulations in healthy subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 5, p. 353, doi. 10.1002/cpdd.95
- By:
- Publication type:
- Article
Works matching IS 2160763X AND DT 2014 AND VI 3 AND IP 5
Results: 13
1
2
Pharmacokinetics of darunavir after administration of an oral suspension with low-dose ritonavir and with or without food.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 5, p. 346, doi. 10.1002/cpdd.88
- By:
- Publication type:
- Article
3
Population pharmacokinetic and pharmacodynamic analysis of plasma Aβ<sub>40</sub> and Aβ<sub>42</sub> following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 5, p. 396, doi. 10.1002/cpdd.130
- By:
- Publication type:
- Article
4
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 5, p. i, doi. 10.1002/cpdd.68
- Publication type:
- Article
5
Effect of carbamazepine on the pharmacokinetics of paliperidone extended-release tablets at steady-state.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 5, p. 371, doi. 10.1002/cpdd.122
- By:
- Publication type:
- Article
6
Effects of omeprazole and ritonavir on absorption and elimination of the hepatitis C virus NS5A inhibitor GSK2336805 in healthy adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 5, p. 338, doi. 10.1002/cpdd.104
- By:
- Publication type:
- Article
7
Statistical analysis of Amenamevir (ASP2151) between pharmacokinetics and clinical efficacies with non-linear effect model for the treatment of genital herpes.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 5, p. 365, doi. 10.1002/cpdd.108
- By:
- Publication type:
- Article
8
Letter to the editor regarding: 'Pharmacokinetics of teneligliptin in subjects with renal impairment.' Halabi et al., Clinical Pharmacology in Drug Development 2013;2:246-254.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 5, p. 417, doi. 10.1002/cpdd.119
- By:
- Publication type:
- Article
9
Antiretroviral boosting by cobicistat, a structural analog of ritonavir.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
10
Pharmacokinetics and bioavailability of a new testosterone gel formulation in comparison to Testogel® in healthy men.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 5, p. 358, doi. 10.1002/cpdd.110
- By:
- Publication type:
- Article
11
Safety and pharmacokinetics of olokizumab, an anti-IL-6 monoclonal antibody, administered to healthy male volunteers: A randomized phase I study.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 5, p. 388, doi. 10.1002/cpdd.121
- By:
- Publication type:
- Article
12
Pharmacokinetic interactions between topiramate and diltiazem, hydrochlorothiazide, or propranolol.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 5, p. 378, doi. 10.1002/cpdd.107
- By:
- Publication type:
- Article
13
Pharmacokinetics of rabeprazole granules versus tablets, and the effect of food on the pharmacokinetics of rabeprazole granules in healthy adults-cross-study comparison.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 5, p. 406, doi. 10.1002/cpdd.118
- By:
- Publication type:
- Article